https://www.ibisworld.com/about/termsofuse/https://www.ibisworld.com/about/termsofuse/
Major companies have continued to dominate medical device manufacturing, making strategic acquisitions and heavily investing in research and development (R&D) to boost market share. Industry giants like Johnson & Johnson and Boston Scientific have actively pursued acquisitions to expand their portfolios and strengthen their market positions. Johnson & Johnson's 2022 acquisition of Abiomed fortified its place in treating cardiovascular diseases, and Boston Scientific's 2023 acquisition of Axionics expanded its urology product offerings. At the same time, high demand for healthcare from the aging population has made room for an influx of start-ups. Revenue has been climbing at a CAGR of 1.2% to an estimated $56.4 billion over the five years through 2025, including an expected lift of 3.1% in 2024 alone. Innovation has remained a pivotal element in securing growth for medical device manufacturers. Advances in technology and research have led to the development of sophisticated products that can treat rare chronic conditions and ailments. New smart implantable devices, like Biotronik's Dynagen A3 cardiac defibrillator, enhance physicians' ability to treat patients. Government support has been a solid boon for manufacturers, with initiatives like revamped R&D tax credits fuelling innovation. Medical device manufacturers are increasingly focusing on personalizing products and integrating AI, as seen with Medtronic's Genius GI endoscopy tool, allowing them to cater to specific patient needs and improve healthcare outcomes. Since healthcare professionals are under pressure to use the best tools available, the release of new innovative products has directly spurred sales and pushed revenue upward. Buyers' reliance on effective medical devices gives manufacturers significant control over prices, allowing them to maintain solid profit despite swelling R&D budgets. Demographic changes and technological advancements will continue enabling medical device manufacturers to drive revenue growth. As the median age of the U.S. population climbs, demand for orthopedic and neurological devices will surge. Companies will continue investing heavily in R&D to outpace competition in domestic and international markets. Upcoming regulatory changes and potential tariffs under the second Trump administration could present opportunities and challenges, easing regulations but deterring international trade. Despite these hurdles, revenue is set to outpace the previous period's growth, surging at a CAGR of 2.6% to an estimated $64.3 billion through the end of 2030.
In 2023, the medical device market was worth approximately *** billion U.S. dollars in the United States. Throughout the time interval, the revenue in the medical device market increased year-on-year, except for the pandemic-affected 2020.
https://www.kenresearch.com/terms-and-conditionshttps://www.kenresearch.com/terms-and-conditions
Unlocking the Future: US Medical Devices Market 2027. Discover trends, leading MedTech companies, and industry insights with Ken Research.
Medical Devices Market Size 2025-2029
The medical devices market size is forecast to increase by USD 223 billion, at a CAGR of 6.5% between 2024 and 2029. The market is witnessing significant growth, driven by the increasing prevalence of diseases and the emergence of innovative medical technologies. The market is experiencing a surge in demand due to the rising burden of chronic diseases and the growing aging population.
Major Market Trends & Insights
North America dominated the market and accounted for a 37% share in 2023.
The market is expected to grow significantly in Europe region as well over the forecast period.
Based on the End-user, the hospitals and ASCs segment led the market and was valued at USD 430.60 billion of the global revenue in 2023.
Based on the Product Type, the diagnostic devices segment accounted for the largest market revenue share in 2023.
Market Size & Forecast
Market Opportunities: USD 597.90 Billion
Future Opportunities: USD 223 Billion
CAGR (2024-2029): 6.5%
North America: Largest market in 2023
The market continues to evolve, driven by advancements in technology and the growing demand for innovative solutions across various sectors. Cardiovascular device technology, for instance, has seen significant progress with the development of more efficient and effective stents, leading to a 5% annual growth rate. Surgical instrument design has been revolutionized by surgical robotics systems, enabling minimally invasive procedures and improved therapeutic device efficacy. Three-dimensional printed implants are another area of focus, with biomaterial compatibility testing ensuring optimal patient safety and long-term success. Regulatory device compliance remains a critical factor, as mobile health applications and artificial intelligence diagnostics gain popularity.
What will be the Size of the Medical Devices Market during the forecast period?
Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample
Advanced medical devices, such as implantable devices and diagnostic equipment, are increasingly being adopted to improve patient outcomes and enhance the quality of healthcare. However, the market faces challenges in the form of declining reimbursement and cost containment measures. Healthcare providers and insurers are increasingly focusing on cost savings, leading to pressure on medical device manufacturers to reduce prices. The clinics segment is the second largest segment of the end-user and was valued at USD 104.10 billion in 2023.
Additionally, regulatory compliance and stringent approval processes pose significant challenges to market entrants. Companies must navigate these challenges by developing cost-effective solutions, focusing on regulatory compliance, and collaborating with healthcare providers and insurers to ensure reimbursement for their products. To capitalize on the market opportunities and stay competitive, companies must invest in research and development to bring innovative products to market and collaborate with healthcare providers to address unmet clinical needs.
Neurological device implantation and in-vitro diagnostic testing are also seeing advancements, with precision medicine devices and machine learning algorithms driving diagnostic accuracy. In the realm of diabetes management systems, remote patient monitoring and wearable health trackers are transforming care delivery. Respiratory device performance and drug delivery systems are being optimized for better patient outcomes. Advanced wound care and rehabilitation device technology are also making strides, with connected medical devices and telemedicine platforms facilitating remote care. The market for implantable devices, such as orthopedic implants, is expected to grow at a steady pace, driven by improvements in implantable device design and device cybersecurity standards.
Biomedical device sterilization methods continue to evolve, ensuring patient safety and reducing the risk of infection. A notable example of market dynamism is the integration of health data analytics into clinical trial protocols and patient safety protocols, streamlining research and improving patient care. Overall, the market is characterized by continuous innovation and adaptation to meet the evolving needs of healthcare providers and patients.
How is this Medical Devices Industry segmented?
The medical devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.
End-user
Hospitals and ASCs
Clinics
Others
Product Type
Diagnostic devices
Therapeutic devices
Monitoring devices
Assistive and rehabilitation devices
Others
Application
Cardiovascular
Ort
https://www.ibisworld.com/about/termsofuse/https://www.ibisworld.com/about/termsofuse/
Number of Businesses statistics on the Medical Device Manufacturing industry in the US
The revenue in the 'Medical Devices' segment of the medical technology market in the United States was forecast to continuously increase between 2024 and 2029 by in total **** billion U.S. dollars (+***** percent). After the ninth consecutive increasing year, the revenue is estimated to reach ****** billion U.S. dollars and therefore a new peak in 2029. Find further information concerning the revenue in the medical technology market in the Dominican Republic and the revenue in the medical technology market in Italy. The Statista Market Insights cover a broad range of additional markets.
https://www.expertmarketresearch.com/privacy-policyhttps://www.expertmarketresearch.com/privacy-policy
The United States medical devices market was valued at USD 197.14 Billion in 2024, driven by rapid technological advancements, strong regulatory support, and a robust innovation ecosystem across the region. It is expected to grow at a CAGR of 6.20% during the forecast period of 2025-2034 and attain a market value of USD 359.77 Billion by 2034. The presence of a well-established FDA approval process is fostering trust and accelerating new product launches.
Demographics also play a role. An aging population with chronic conditions like diabetes, cardiovascular disease, and arthritis is increasing demand for long-term care solutions. Hospitals are upgrading equipment to meet new standards, and outpatient centers are purchasing portable and user-friendly systems to manage costs and improve throughput.
Private sector funding is flowing into innovation hubs in cities like Boston, San Diego, and Minneapolis. These ecosystems combine academic research, clinical trials, and manufacturing in one pipeline, giving U.S.-based developers a speed advantage over global competitors. All this adds up to steady market expansion, particularly in high-margin categories like implantable devices, surgical robotics, and smart diagnostics.
The revenue in the 'Medical Devices' segment of the medical technology market in Latin America was forecast to continuously increase between 2024 and 2029 by in total **** billion U.S. dollars (+***** percent). After the ninth consecutive increasing year, the revenue is estimated to reach **** billion U.S. dollars and therefore a new peak in 2029. Find further information concerning the revenue in the 'In Vitro Diagnostics' segment of the medical technology market in Spain and the revenue in the 'Ophthalmic Devices' segment of the medical technology market in Indonesia. The Statista Market Insights cover a broad range of additional markets.
https://www.astuteanalytica.com/privacy-policyhttps://www.astuteanalytica.com/privacy-policy
The U.S. Medical Devices Market is projected to reach USD 311.50 billion by 2033, growing at a CAGR of 5.9% from 2025-2033.
https://media.market.us/privacy-policyhttps://media.market.us/privacy-policy
Global Medical Device Outsourcing Market size is expected to be worth around US$ 352.3 Billion by 2032 from US$ 130.7 Billion in 2023, growing at a CAGR of 12.0% during the forecast period from 2023 to 2032. In 2022, Asia Pacific led the market, achieving over 40.6% share with a revenue of US$ 47.3 Billion.
This market's robust growth is fueled by rising demand for medical devices, increasing price competition, and the need for cost efficiencies. Complexities in product engineering and the influx of new market entrants further drive demand for outsourcing services. A strong focus on innovative technologies and the development of patient-centric devices is expected to boost medical device pipelines throughout the forecast period.
Stringent regulatory requirements, such as those imposed by the FDA and EMA, have led companies to outsource compliance processes, simplifying adherence and fostering market growth. The COVID-19 pandemic initially redirected clinical trial priorities toward COVID-related diagnostics and treatments. However, post-pandemic, there has been a shift toward oncology and central nervous system disease research, signaling diversification in clinical trials.
Outsourcing in the medical device sector offers companies significant benefits, including efficient management of routine manufacturing tasks, cost savings, and streamlined supply chains. These advantages enable the rapid delivery of competitive products to market while maintaining compliance with industry standards. Accelerated production timelines also facilitate quicker market entry.
Additionally, broader healthcare trends, such as the rising adoption of minimally invasive procedures for chronic disease treatment, are driving demand for outsourcing services. These trends create new opportunities for outsourcing firms, allowing them to support innovation and product development.
Emerging markets are playing a vital role in the growth of the medical device outsourcing sector. Increased demand for high-quality healthcare services in these regions has led outsourcing firms to focus on obtaining swift regulatory approvals and ensuring timely product launches. This capability supports faster market penetration and is expected to further accelerate market growth.
https://mobilityforesights.com/page/privacy-policyhttps://mobilityforesights.com/page/privacy-policy
In US Medical Device Market, advanced insulin pump system from Medtronic boasts an automated closed-loop algorithm that automatically adjusts insulin delivery based on real-time glucose levels, significantly reducing the burden of managing diabetes for patients.
https://www.mordorintelligence.com/privacy-policyhttps://www.mordorintelligence.com/privacy-policy
The Single-Use Medical Device Reprocessing Market report segments the industry into By Device Type (Class I Devices, Class II Devices) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). Get five years of historical data alongside five-year market forecasts.
https://www.marketresearchforecast.com/privacy-policyhttps://www.marketresearchforecast.com/privacy-policy
The U.S. Medical Devices Marketsize was valued at USD 184.61 USD Billion in 2023 and is projected to reach USD 279.42 USD Billion by 2032, exhibiting a CAGR of 6.1 % during the forecast period.Medical devices comprise of equipment, apparatuses, various machines and implants as well as software used in the medical field for the purposes of identification of a disease or injury, prevention from disease or injury, monitoring or treatment or alleviation of disease or injury. There is a variety of these devices which is ranging from the simple gadgets like a thermometer and blood pressure monitor to the sophisticated diagnostic and treatment systems such as MRI machines and robotic surgical tools. One of the essential points of medical devices is the accuracy, precision, safety, and effectiveness of their operations. Offering a full spectrum of medical services to meet various health requirements, work towards better patient outcomes, and improve the healthcare efficiency are of the main objectives these facilities. The role of medical devices also sees personalized medicine by the pharmaceutical sector as its manufacturers continue to produce devices that can be adjusted to fit individual patient profiles. The influence of medical devices is diverse with applications in RFID tracking and remote patient monitoring, telemedicine, accessibility and economy. With them as tools, health providers can collect real-time information, make integral intercessions, and prevent potential issues from progressing. In conclusion, as well, medical devices open up the way to research, innovation, and medical technology progression, which is serving for an effective, continuous development of patient care and medical practice. Key drivers for this market are: Increasing Adoption of Synthetic BVF to Boost Market Growth. Potential restraints include: High Cost of Devices to Limit their Adoption in Small & Mid-sized Facilities. Notable trends are: Increasing Number of Hospitals and ASCs Identified as Significant Market Trend.
https://www.transparencymarketresearch.com/privacy-policy.htmlhttps://www.transparencymarketresearch.com/privacy-policy.html
Pediatric Medical Devices Market Snapshot
Attribute | Detail |
---|---|
Market Size in 2022 | US$ 27.6 Bn |
Market Forecast (Value) in 2031 | US$ 47.4 Bn |
Growth Rate (CAGR) | 6.3% |
Forecast Period | 2023-2031 |
Historical Data Available for | 2017-2021 |
Quantitative Units | US$ Bn for Value |
Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis. |
Competition Landscape |
|
Format | Electronic (PDF) + Excel |
Market Segmentation |
|
Regions Covered |
|
Countries Covered |
|
Companies Profiled |
|
Customization Scope | Available upon request |
Pricing | Available upon request |
https://www.mordorintelligence.com/privacy-policyhttps://www.mordorintelligence.com/privacy-policy
The Report Covers North America Medical Device Reprocessing Companies and the market is segmented by Device (Class I Devices, Class II Devices) and Geography.
https://www.techsciresearch.com/privacy-policy.aspxhttps://www.techsciresearch.com/privacy-policy.aspx
United States Wearable Medical Devices Market was valued at USD 4.44 Billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 19.13%.
Pages | 85 |
Market Size | 2024: USD 4.44 Billion |
Forecast Market Size | 2030: USD 12.60 Billion |
CAGR | 2025-2030: 19.13% |
Fastest Growing Segment | Diagnostic Devices |
Largest Market | Western Region |
Key Players | 1. Abbott Laboratories, Inc. 2. Fitbit, Inc. 3. Apple, Inc. 4. GE Healthcare 5. Masimo Corporation 6. Dexcom Inc. 7. Biotelemetry Inc. 8. iRhythm Technologies, Inc. 9. Preventice Solutions, Inc. 10. Medtronic plc |
https://mobilityforesights.com/page/privacy-policyhttps://mobilityforesights.com/page/privacy-policy
US Medical Devices Market is poised for continued growth, driven by technological advancements, rising healthcare needs.
This statistic shows the market size of medical device coatings in the United States in 2014 and 2015, with forecasted figures for 2016 to 2024, by product. In 2015, the U.S. medical device antimicrobial coatings market was worth some *** million U.S. dollars. It is forecasted to grow to nearly *** billion U.S. dollars by 2024.
Medical Technologies Market Size 2025-2029
The medical technologies market size is forecast to increase by USD 346.4 billion, at a CAGR of 8% between 2024 and 2029.
The market is experiencing significant growth, driven by the increasing prevalence of diseases and the growing use of connected devices and technologies. Public health surveillance and digital therapeutics are transforming disease prevention and treatment, while speech therapy and behavioral health technologies are addressing the growing need for mental health services. The advancements in medical technology are enabling early disease detection and diagnosis, leading to improved patient outcomes and reduced healthcare costs. Furthermore, the integration of technology in healthcare is enhancing the overall patient experience and facilitating remote monitoring and telemedicine services. However, the market faces challenges in the form of declining reimbursement and cost containment measures.
Additionally, regulatory requirements and compliance issues can pose significant challenges for market participants. Companies must navigate these obstacles by focusing on innovation, cost reduction, and regulatory compliance to remain competitive and capitalize on the market's potential. As healthcare costs continue to rise, payers are increasingly looking for cost-effective solutions, which may limit the adoption of advanced medical technologies. Medical regulations and data analytics shape the industry, ensuring compliance and informed decision-making.
What will be the Size of the Medical Technologies Market during the forecast period?
Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample
The market continues to evolve, driven by advancements in various sectors. Supply chain management optimizes the distribution of surgical instruments, therapeutic devices, and pharmaceutical research products. Robotics in surgery and laser technology enhance minimally invasive procedures, while healthcare IT streamlines medical billing and insurance claims processing. Regulatory affairs ensure safety and efficacy of medical devices, from implantable devices to drug delivery systems. Patient engagement is facilitated through wearable sensors and remote patient monitoring, enabling preventive medicine and chronic disease management. Predictive analytics and precision medicine offer personalized treatment plans, revolutionizing disease management.
Sterilization techniques and hospital management systems maintain high standards of hygiene and efficiency. Medical lasers and radiation therapy provide precise interventions, while medical imaging software and diagnostic imaging offer accurate diagnoses. The ongoing unfolding of market activities shapes the landscape of medical technologies, with distribution channels and public health remaining key considerations. Regenerative medicine holds great potential, with ongoing clinical trials and nanotechnology in medicine pushing the boundaries of healing.
How is this Medical Technologies Industry segmented?
The medical technologies industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.
Application
Medical devices
In-vitro diagnostics
End-user
Hospitals
Clinics
Others
Component
Hardware
Services
Software
Geography
North America
US
Canada
Mexico
Europe
France
Germany
Italy
UK
APAC
China
India
Japan
Rest of World (ROW)
By Application Insights
The medical devices segment is estimated to witness significant growth during the forecast period. The medical devices market encompasses instruments, apparatus, appliances, materials, and articles utilized for disease diagnosis, prevention, monitoring, treatment, and relief. Major categories include therapeutic and surgical devices, patient monitoring and diagnostic devices (PMDMIDs), and other medical devices. Factors fueling market expansion include the increasing disease prevalence and related risk factors, an aging population, public and private initiatives to promote health awareness, and escalating healthcare expenditures. For instance, the European Union is projected to have approximately 22.4% of its population aged 65 and above by 2024. Quality control is a critical aspect of medical devices, ensuring their safety and effectiveness.
Robotics in surgery and minimally invasive procedures enhance precision and reduce complications. Medical billing and insurance claims processing streamline financial transactions. Medical lasers, pharmaceutical research, and drug delivery systems advance treatment modalities. Health informatics, rem
https://dataintelo.com/privacy-and-policyhttps://dataintelo.com/privacy-and-policy
The global surgical and medical device market is projected to experience significant growth, with its market size estimated to reach approximately $650 billion by 2023, and a forecasted expansion to $1.1 trillion by 2032, reflecting a compound annual growth rate (CAGR) of approximately 6.3%. This growth is primarily driven by the increasing prevalence of chronic diseases, advancements in medical technology, and the rising demand for minimally invasive surgical procedures. Furthermore, the growing aging population and the expansion of healthcare infrastructure in emerging economies are anticipated to further fuel market growth throughout the forecast period.
One of the key growth factors for the surgical and medical device market is the rapid advancement in medical technology, which has led to the development of innovative and efficient devices. Technological advancements such as robotic-assisted surgeries, augmented reality in the operating room, and the integration of artificial intelligence in diagnostic imaging are transforming the landscape of surgical procedures. These innovations not only enhance the precision and outcomes of surgeries but also reduce recovery times, thereby increasing the demand for advanced surgical devices. Additionally, the continual research and development efforts by manufacturers to introduce cutting-edge products are further propelling market expansion.
The increasing prevalence of chronic diseases such as cardiovascular diseases, diabetes, and cancer is another significant driver of the surgical and medical device market. As these conditions often require surgical intervention, the demand for surgical devices and equipment is on the rise. According to the World Health Organization, non-communicable diseases are responsible for 71% of all deaths globally, underscoring the need for effective medical devices to manage these conditions. Furthermore, the growing awareness among patients and healthcare professionals about early disease detection and preventive healthcare is leading to a higher adoption of diagnostic and monitoring devices, further boosting market growth.
The expanding healthcare infrastructure in emerging economies presents a substantial opportunity for the surgical and medical device market. Countries in the Asia Pacific and Latin America regions are witnessing significant investments in healthcare facilities, aimed at improving accessibility and the quality of healthcare services. This expansion is accompanied by an increasing number of healthcare professionals and a growing focus on medical tourism, particularly in countries like India and Thailand. As a result, the demand for surgical and medical devices is expected to rise, providing lucrative opportunities for market players to expand their presence in these regions.
Regionally, North America currently dominates the surgical and medical device market, attributed to the presence of a robust healthcare system, high adoption of advanced technologies, and the presence of key market players. However, the Asia Pacific region is anticipated to witness the highest growth rate during the forecast period, driven by the factors mentioned earlier, such as expanding healthcare infrastructure and increasing medical tourism. In contrast, Europe is expected to experience steady growth, supported by the well-established healthcare sector and the rising geriatric population necessitating medical interventions. Meanwhile, the Middle East & Africa region is projected to witness moderate growth due to improving healthcare systems and investments in healthcare infrastructure.
The market for Used Medical Device Sales is also gaining traction as healthcare facilities and smaller clinics look for cost-effective solutions to equip their operations. This segment is particularly appealing in emerging markets where budget constraints often limit the acquisition of brand-new equipment. Used medical devices offer a viable alternative, providing essential functionalities at a fraction of the cost. Additionally, the refurbishment and resale of medical devices contribute to sustainability efforts by extending the lifecycle of equipment and reducing electronic waste. As the demand for healthcare services continues to rise, the market for used medical devices is expected to grow, offering opportunities for both sellers and buyers in the industry.
The product type segment of the surgical and medical devic
https://www.ibisworld.com/about/termsofuse/https://www.ibisworld.com/about/termsofuse/
Major companies have continued to dominate medical device manufacturing, making strategic acquisitions and heavily investing in research and development (R&D) to boost market share. Industry giants like Johnson & Johnson and Boston Scientific have actively pursued acquisitions to expand their portfolios and strengthen their market positions. Johnson & Johnson's 2022 acquisition of Abiomed fortified its place in treating cardiovascular diseases, and Boston Scientific's 2023 acquisition of Axionics expanded its urology product offerings. At the same time, high demand for healthcare from the aging population has made room for an influx of start-ups. Revenue has been climbing at a CAGR of 1.2% to an estimated $56.4 billion over the five years through 2025, including an expected lift of 3.1% in 2024 alone. Innovation has remained a pivotal element in securing growth for medical device manufacturers. Advances in technology and research have led to the development of sophisticated products that can treat rare chronic conditions and ailments. New smart implantable devices, like Biotronik's Dynagen A3 cardiac defibrillator, enhance physicians' ability to treat patients. Government support has been a solid boon for manufacturers, with initiatives like revamped R&D tax credits fuelling innovation. Medical device manufacturers are increasingly focusing on personalizing products and integrating AI, as seen with Medtronic's Genius GI endoscopy tool, allowing them to cater to specific patient needs and improve healthcare outcomes. Since healthcare professionals are under pressure to use the best tools available, the release of new innovative products has directly spurred sales and pushed revenue upward. Buyers' reliance on effective medical devices gives manufacturers significant control over prices, allowing them to maintain solid profit despite swelling R&D budgets. Demographic changes and technological advancements will continue enabling medical device manufacturers to drive revenue growth. As the median age of the U.S. population climbs, demand for orthopedic and neurological devices will surge. Companies will continue investing heavily in R&D to outpace competition in domestic and international markets. Upcoming regulatory changes and potential tariffs under the second Trump administration could present opportunities and challenges, easing regulations but deterring international trade. Despite these hurdles, revenue is set to outpace the previous period's growth, surging at a CAGR of 2.6% to an estimated $64.3 billion through the end of 2030.